Ceramides mediate cigarette smoke-induced metabolic disruption in mice

American Journal of Physiology - Endocrinology and Metabolism

Volumn 307, Issue 10, 2014, Pages E919-E927

  Thatcher, Mikayla O ^a   Tippetts, Trevor S ^a   Nelson, Michael B ^a   Swensen, Adam C ^b   Winden, Duane R ^a   Hansen, Melissa E ^a   Anderson, Madeline C ^a   Johnson, Ian E ^a   Porter, James P ^a   Reynolds, Paul R ^a   Bikman, Benjamin T ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

^b N243 Eyring Science Center   (United States)

Author keywords

Ceramide; Cigarette smoke; Insulin resistance; Metabolic disruption; Mitochondria

Indexed keywords

CERAMIDE; CIGARETTE SMOKE; THERMOZYMOCIDIN; CARBOHYDRATE; INSULIN; MONOUNSATURATED FATTY ACID; SMOKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GLUCOSE INTAKE; INSULIN RESISTANCE; LIPID DIET; LUNG ALVEOLUS CELL; MALE; METABOLIC DISORDER; MITOCHONDRIAL RESPIRATION; MOUSE; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; ADVERSE EFFECTS; ANIMAL; CELL RESPIRATION; LUNG; METABOLISM; MITOCHONDRION; SIGNAL TRANSDUCTION; SMOKE; TOBACCO; TOXICITY;

ANIMALS; CARBOHYDRATES; CELL RESPIRATION; CERAMIDES; DIET, HIGH-FAT; FATTY ACIDS, MONOUNSATURATED; INSULIN; INSULIN RESISTANCE; LUNG; MICE; MITOCHONDRIA; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; SIGNAL TRANSDUCTION; SMOKE; TOBACCO;

EID: 84924767916     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00258.2014     Document Type: Article

References (53)

1. Anonymous. Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings. Washington, DC: Substance Abuse and Mental Health Services Administration, 2011.
2. Anonymous. Vital signs: nonsmokers' exposure to secondhand smoke- United States, 1999-2008. Morbid Mortal Weekly Report 59: 1141-1146, 2010.
3. Agarwal AR, Yin F, Cadenas E. Short-term cigarette smoke exposure leads to metabolic alterations in lung alveolar cells. Am J Respir Cell Mol Biol, 2014.
4. Attvall S, Fowelin J, Lager I, Von Schenck H, Smith U. Smoking induces insulin resistance-a potential link with the insulin resistance syndrome. J Int Med 233: 327-332, 1993.
5. Barreiro E, del Puerto-Nevado L, Puig-Vilanova E, Perez-Rial S, Sanchez F, Martinez-Galan L, Rivera S, Gea J, Gonzalez-Mangado N, Peces-Barba G. Cigarette smoke-induced oxidative stress in skeletal muscles of mice. Respir Physiol Neurobiol 182: 9-17, 2012.
6. Bergman BC, Perreault L, Hunerdosse D, Kerege A, Playdon M, Samek AM, Eckel RH. Novel and reversible mechanisms of smokinginduced insulin resistance in humans. Diabetes 61: 3156-3166, 2012.
7. Bikman BT. A role for sphingolipids in the pathophysiology of obesityinduced inflammation. Cell Mol Life Sci 69: 2135-2146, 2012.
8. Bikman BT, Guan Y, Shui G, Siddique MM, Holland WL, Kim JY, Fabrias G, Wenk MR, Summers SA. Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis. J Biol Chem 287: 17426-17437, 2012.
9. Bikman BT, Summers SA. Ceramides as modulators of cellular and whole-body metabolism. J Clin Invest 121: 4222-4230, 2011.
10. Borissova AM, Tankova T, Kirilov G, Dakovska L, Krivoshiev S. The effect of smoking on peripheral insulin sensitivity and plasma endothelin level. Diabetes Metab 30: 147-152, 2004.
11. Bray GA, Champagne CM. Beyond energy balance: there is more to obesity than kilocalories. J Am Diet Assoc 105: S17-23, 2005.
12. Chavez JA, Knotts TA, Wang LP, Li G, Dobrowsky RT, Florant GL, Summers SA. A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids. J Biol Chem 278: 10297-10303, 2003.
13. Chen CC, Li TC, Chang PC, Liu CS, Lin WY, Wu MT, Li CI, Lai MM, Lin CC. Association among cigarette smoking, metabolic syndrome, and its individual components: the metabolic syndrome study in Taiwan. Metab Clin Exper 57: 544-548, 2008.
14. Chen H, Vlahos R, Bozinovski S, Jones J, Anderson GP, Morris MJ. Effect of short-term cigarette smoke exposure on body weight, appetite and brain neuropeptide Y in mice. Neuropsychopharmacology 30: 713- 719, 2005.
15. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr 87: 801-809, 2008.
16. Contreras FX, Villar AV, Alonso A, Kolesnick RN, Goni FM. Sphingomyelinase activity causes transbilayer lipid translocation in model and cell membranes. J Biol Chem 278: 37169-37174, 2003.
17. DeFronzo RA, Ferrannini Insulin resistance E. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14: 173-194, 1991.
18. Du J, Wang Y, Hunter R, Wei Y, Blumenthal R, Falke C, Khairova R, Zhou R, Yuan P, Machado-Vieira R, McEwen BS, Manji HK. Dynamic regulation of mitochondrial function by glucocorticoids. Proc Natl Acad Sci USA 106: 3543-3548, 2009.
19. Ebersbach-Silva P, Alves T, Fonseca AT, Oliveira MA, Machado UF, Seraphim PM. Cigarette smoke exposure severely reduces peripheral insulin sensitivity without changing GLUT4 expression in oxidative muscle of Wistar rats. Arquiv Brasil Endocrinol Metabol 57: 19-26, 2013.
20. Eliasson B, Mero N, Taskinen MR, Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 129: 79-88, 1997.
21. Erickson KA, Smith ME, Anthonymuthu TS, Evanson MJ, Brassfield ES, Hodson AE, Bressler MA, Tucker BJ, Thatcher MO, Prince JT, Hancock CR, Bikman BT. AICAR inhibits ceramide biosynthesis in skeletal muscle. Diabetol Metab Syndrome 4: 45, 2012.
22. Facchini FS, Hollenbeck CB, Jeppesen J, Chen YD, Reaven GM. Insulin resistance and cigarette smoking. Lancet 339: 1128-1130, 1992.
23. Gannon AM, Stampfli MR, Foster WG. Cigarette smoke exposure elicits increased autophagy and dysregulation of mitochondrial dynamics in murine granulosa cells. Biol Reprod 88: 63, 2013.
24. Goldkorn T, Filosto S. Lung injury and cancer: Mechanistic insights into ceramide and EGFR signaling under cigarette smoke. Am J Respir Cell Mol Biol 43: 259-268, 2010.
25. Gudz TI, Tserng KY, Hoppel CL. Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide. J Biol Chem 272: 24154-24158, 1997.
26. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 41: 715-722, 1992.
27. Hamabe A, Uto H, Imamura Y, Kusano K, Mawatari S, Kumagai K, Kure T, Tamai T, Moriuchi A, Sakiyama T, Oketani M, Ido A, Tsubouchi H. Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. J Gastroenterol 46: 769-778, 2011.
28. Hebert JR, Kabat GC. Differences in dietary intake associated with smoking status. Eur J Clin Nutr 44: 185-193, 1990.
29. Hofstetter A, Schutz Y, Jequier E, Wahren J. Increased 24-hour energy expenditure in cigarette smokers. New Engl J Med 314: 79-82, 1986.
30. Hustvedt BE, Lovo A. Correlation between hyperinsulinemia and hyperphagia in rats with ventromedial hypothalamic lesions. Acta Physiol Scand 84: 29-33, 1972.
31. Jha P. Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer 9: 655-664, 2009.
32. Jheng HF, Tsai PJ, Guo SM, Kuo LH, Chang CS, Su IJ, Chang CR, Tsai YS. Mitochondrial fission contributes to mitochondrial dysfunction and insulin resistance in skeletal muscle. Mol Cell Biol 32: 309-319, 2012.
33. John U, Hanke M, Rumpf HJ, Thyrian JR. Smoking status, cigarettes per day, and their relationship to overweight and obesity among former and current smokers in a national adult general population sample. Int J Obes (Lond) 29: 1289-1294, 2005.
34. Knight-Lozano CA, Young CG, Burow DL, Hu ZY, Uyeminami D, Pinkerton KE, Ischiropoulos H, Ballinger SW. Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 105: 849-854, 2002.
35. Levy M, Khan E, Careaga M, Goldkorn T. Neutral sphingomyelinase 2 is activated by cigarette smoke to augment ceramide-induced apoptosis in lung cell death. Am J Physiol Lung Cell Mol Physiol 297: L125-L133, 2009.
36. Makimattila S, Nikkila K, Yki-Jarvinen H. Causes of weight gain during insulin therapy with and without metformin in patients with Type II diabetes mellitus. Diabetologia 42: 406-412, 1999.
37. Miro O, Alonso JR, Jarreta D, Casademont J, Urbano-Marquez A, Cardellach F. Smoking disturbs mitochondrial respiratory chain function and enhances lipid peroxidation on human circulating lymphocytes. Carcinogenesis 20: 1331-1336, 1999.
38. Pesta D, Gnaiger E. High-resolution respirometry: OXPHOS protocols for human cells and permeabilized fibers from small biopsies of human muscle. Methods Mol Biol 810: 25-58, 2012.
39. Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29: e45, 2001.
40. Pirkle JL, Bernert JT, Caudill SP, Sosnoff CS, Pechacek TF. Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke: 1988-2002. Environ Health Persp 114: 853-858, 2006.
41. Pirkle JL, Flegal KM, Bernert JT, Brody DJ, Etzel RA, Maurer KR. Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA 275: 1233-1240, 1996.
42. Rajagopalan S, Brook RD. Air pollution and type 2 diabetes: mechanistic insights. Diabetes 61: 3037-3045, 2012.
43. Reaven G, Tsao PS. Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? J Am Coll Cardiol 41: 1044-1047, 2003.
44. Reaven GM, Chen YD. Insulin resistance and cigarette smoking. Lancet 340: 377, 1992.
45. Reynolds PR, Cosio MG, Hoidal JR. Cigarette smoke-induced Egr-1 upregulates proinflammatory cytokines in pulmonary epithelial cells. American J Respir Cell Mol Biol 35: 314-319, 2006.
46. Shimokata H, Muller DC, Andres R. Studies in the distribution of body fat. III. Effects of cigarette smoking. JAMA 261: 1169-1173, 1989.
47. Smith ME, Tippetts TS, Brassfield ES, Tucker BJ, Ockey A, Swensen AC, Anthonymuthu TS, Washburn TD, Kane DA, Prince JT, Bikman BT. Mitochondrial fission mediates ceramide-induced metabolic disruption in skeletal muscle. Biochem J 456: 427-439, 2013.
48. Speizer FE. Getting some breathing room-persuading patients to stop smoking. Western J Med 157: 585-586, 1992.
49. Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 45: 42-72, 2006.
50. Velasquez-Mieyer PA, Cowan PA, Arheart KL, Buffington CK, Spencer KA, Connelly BE, Cowan GW, Lustig RH. Suppression of insulin secretion is associated with weight loss and altered macronutrient intake and preference in a subset of obese adults. Int J Obes Rel Metab Dis 27: 219-226, 2003.
51. Watt MJ, Barnett AC, Bruce CR, Schenk S, Horowitz JF, Hoy AJ. Regulation of plasma ceramide levels with fatty acid oversupply: evidence that the liver detects and secretes de novo synthesised ceramide. Diabetologia 55: 2741-2746, 2012.
52. World Health Organization. Obesity and Overweight. http://wwwwhoint/ mediacentre/factsheets/fs311/en/FactSheet311, 2012.
53. Wright JL, Cosio M, Churg A. Animal models of chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol 295: L1-L15, 2008.